Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2622-2634

  Amodio, Nicola ^a,b   Scrima, Marianna ^a   Palaia, Lucia ^a,b   Salman, Ali Naeem ^a   Quintiero, Alfina ^a   Franco, Renato ^c   Botti, Gerardo ^c   Pirozzi, Pino ^c   Rocco, Gaetano ^c   De Rosa, Nicla ^d   Viglietto, Giuseppe ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Institute for Genetic Research IRGS   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d MONALDI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REGULATOR PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE NEDD4;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

EID: 78149295998     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091075     Document Type: Article

References (42)

1. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 2007, 111:1710-1717
2. Gabrielson E: Worldwide trends in lung cancer pathology. Respirology 2006, 11:533-538
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin 2007, 57:43-66
4. Minna JD, Roth JA, Gazdar AF: Focus on lung cancer. Cancer Cell 2002, 1:49-52
5. Altomare DA, Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005, 24:7455-7464
6. Cully M, You H, Levine AJ, Mak TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006, 6:184-192
7. Kawano O, Sasaki H, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y: PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer 2006, 54:209-215 (Pubitemid 44764916)
8. Malanga D, Scrima M, De Marco C, Fabiani F, De Rosa N, De Gisi S, Malara N, Savino R, Rocco G, Chiappetta G, Franco R, Tirino V, Pirozzi G, Viglietto G: Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle 2008, 7:665-669
9. Breuer RH, Postmus PE, Smit EF: Molecular pathology of non-small-cell lung cancer. Respiration 2005, 72:313-330
10. Cantley LC, Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999, 96:4240-4245
11. Di Cristofano A, Pandolfi PP: The multiple roles of PTEN in tumor suppression. Cell 2000, 100:387-390
12. Tang JM, He QY, Guo RX, Chang XJ: Phosphorylated Akt overexpression and loss of PTEN expression in non-small-cell lung cancer confers poor prognosis. Lung Cancer 2006, 51:181-191
13. Lim WT, Zhang WH, Miller CR, Watters JW, Gao F, Viswanathan A, Govindan R, McLeod HL: PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small-cell lung cancer. Oncol Rep 2007, 17:853-857
14. Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri FR: Lack of PTEN expression in non-small-cell lung cancer could be related to promoter methylation. Clin Cancer Res 2002, 8:1178-1184
15. Marsit CJ, Zheng S, Aldape K, Hinds PW, Nelson HH, Wiencke JK, Kelsey KT: PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 2005, 36:768-776
16. Kohno T, Takahashi M, Manda R, Yokota J: Inactivation of the PTEN/ MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 1998, 22:152-156
17. Yokomizo A, Tindall DJ, Drabkin H, Gemmill R, Franklin W, Yang P, Sugio K, Smith DI, Liu W: PTEN/MMAC1 mutations identified in small cell, but not in non-small-cell lung cancers. Oncogene 1998, 17:475-479
18. Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba II, Milchgrub S, Brezinschek R, Virmani A, Gazdar AF, Minna JD: Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene 2008, 17:1557-1565
19. Hosoya Y, Gemma A, Seike M, Kurimoto F, Uematsu K, Hibino S, Yoshimura A, Shibuya M, Kudoh S: Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Lung Cancer 1999, 25:87-93
20. Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL: Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res 2000, 60:35-37
21. Leslie NR, Downes CP: PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004, 382:1-11
22. Torres J, Pulido R: The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus: implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 2001, 276:993-998
23. Wu W, Wang X, Zhang W, Reed W, Samet JM, Whang YE, Ghio AJ: Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J Biol Chem 2003, 278:28258-28263
24. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, Jiang X: NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007, 128:129-139
25. Ingham RJ, Gish G, Pawson T: The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene 2004, 23:1972-1984
26. Fouladkou F, Landry T, Kawabe H, Neeb A, Lu C, Brose N, Stambolic V, Rotin D: The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci USA 2008, 105:8585-8590
27. Hirsh FR, Corrin B, Colby TV: Tumours of the lung. Clinical features and staging. In: WHO Classification, Tumors of the Lung, Pleura, Thymus and Heart. Edited by Travis WD, Brambilla E, Muller-Hermelink E, Harris CC. Lyon, IARC Press, 2004, pp. 16-19
28. Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E: Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol 2001, 70:255-264
29. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris C: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988, 48:1904-1909
30. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
31. Sambrook J, Fritsch EF, Maniatis T (Eds): Molecular Cloning: A Laboratory Manual (2). Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press, 1992
32. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) method. Methods 2001, 25:402-408
33. Saal LH, Gruvberger-Saal SK, Persson C, Lövgren K, Jumppanen M, Staaf J, Jönsson G, Pires MM, Maurer M, Holm K, Koujak S, Subramaniyam S, Vallon-Christersson J, Olsson H, Su T, Memeo L, Ludwig T, Ethier SP, Krogh M, Szabolcs M, Murty VV, Isola J, Hibshoosh H, Parsons R, Borg A: Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 2008, 40:102-107
34. Lague MN, Paquet M, Fan HY, Kaartinen MJ, Chu S, Jamin SP, Behringer RR, Fuller PJ, Mitchell A, Doré M, Huneault LM, Richards JS, Boerboom D: Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis 2008, 29:2062-2072
35. Kim SS, Yoo NJ, Jeong EG, Kim MS, Lee SH: Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas. APMIS 2008, 116:779-784
36. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol 1997, 15:871-875
37. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA: Molecular cytogenetic analysis of non-small-cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 2001, 125:87-99 (Pubitemid 32448052)
38. Endoh H, Yatabe Y, Kosaka T, Kuwano H, Mitsudomi T: PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients. J Thorac Oncol 2006, 1:629-634
39. Olaussen KA, Soria JC, Morat L, Martin A, Sabatier L, Morere JF, Khayat D, Spano JP: Loss of PTEN expression is not uncommon, but lacks prognostic value in stage I NSCLC. Anticancer Res 2003, 6:4885-4890
40. Massion PP, Taflan PM, Shyr Y, Rahman SM, Yildiz P, Shakthour B, Edgerton ME, Ninan M, Andersen JJ, Gonzalez AL: Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med 2004, 170:1088-1094
41. Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT: Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small-cell lung cancer. Anticancer Res 2009, 29:4175-4183
42. Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, Jen J, Dennis PA: Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol 2006, 24:306-314